INBS Intelligent Bio Profit After Tax

Intelligent Bio Solutions develops sweat analysis systems for rapid testing, generating a steady cash flow from the sale of consumables. Management is betting on simplifying screening procedures for law enforcement and corporate clients. The company's excess income on this chart reflects profit dynamics, where the -0.01 indicator determines the metric's value. Rising demand for security automation in logistics is expanding its target markets.

This indicator assesses the current ability of Intelligent Bio Solutions (INBS) to generate net income, focusing on projected market value rather than historical accounting data. Market monopolization driven by Barriers platform patents and FDA certification directly impacts the company's operating net profit, converting a technological advantage into a stable cash flow, which confirms the resilience of your capital.